BREAST SELF EXAMINATION FOR DISABLED WOMEN

研究一再证实，MammaCare@是一种 学习熟练的手工隆胸的有效方法 考试。Mammacare学习系统提高触觉技能 通过训练一名妇女在逼真的人体内检测微小的模拟病变 乳房模型，并将这项技能转移到她的乳房组织。 大约1000万失明和视障妇女和聋人 并且重听女性无法访问所请求的视觉或 MammaCare的听觉训练组件。在第一阶段拨款期间， 构建了一系列自适应的原型系统，并进行了测试 试验性的。结果表明，样机性能显著提高。 提高乳房检查水平的试验组 盲人和视障妇女以及聋人和重听人 女人。第二阶段的提案调查了自适应 1000名在家的妇女制作了原型，其中500人是盲人或视力正常的 另有500名失聪或听力障碍者。结果将会是 确定实验性自适应版本是否足以 允许有感官障碍的女性成功地进行乳房 在家中自我反省。如果得到肯定，这可能带来的好处是 拯救生命的技术将为相当多的人所用 没有得到充分服务的女性。 拟议的商业应用：拟议的适应性产品 对于乳房自我检查(BSE)有很大的潜在受众。那里 美国大约有1000万失明或失聪的妇女 谁可能因此能够使用申请人的系统 SBIR/第二阶段调查

Research studies have repeatedly confirmed that MammaCare@ is an effective method of learning to perform a competent manual breast examination. The MammaCare Learning System advances tactile skills by training a woman to detect small simulated lesions in a lifelike breast model and transferring that skill to her breast tissue. Approximately 10 million blind and visually impaired women and deaf and hard-of-hearing women cannot access the requested visual or auditory training components of MammaCare. During the Phase I grant, a series of adaptive prototype systems were constructed and tested experimentally. The results indicate that the prototypes significantly improve breast-examination proficiency in the experimental groups of blind and visually impaired women and deaf and hard-of-hearing women. The Phase II proposal investigates the use of the adaptive prototypes by 1,000 women at home, 500 of whom are blind or visually impaired and 500 who are deaf or hard-of-hearing. The results will establish whether the experimental adaptive versions are sufficient to allow women with sensory impairments to successfully conduct breast self-examinations at home. If affirmed, the benefits of this potentially life-saving technology will become available to a substantial population of underserved women. PROPOSED COMMERCIAL APPLICATION: The proposed adaptive products for breast self-examination (BSE) have a large potential audience. There are approximately 10 million blind or deaf women in the United States who may be able to use the applicant's system as a result of this SBIR/PhaseII investigation